267 related articles for article (PubMed ID: 29152256)
1. Consumption of kiwifruit capsules increases
Blatchford P; Stoklosinski H; Eady S; Wallace A; Butts C; Gearry R; Gibson G; Ansell J
J Nutr Sci; 2017; 6():e52. PubMed ID: 29152256
[TBL] [Abstract][Full Text] [Related]
2. A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression.
Jiang S; Xie S; Lv D; Zhang Y; Deng J; Zeng L; Chen Y
Antonie Van Leeuwenhoek; 2016 Oct; 109(10):1389-96. PubMed ID: 27431681
[TBL] [Abstract][Full Text] [Related]
3. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.
Fujimoto T; Imaeda H; Takahashi K; Kasumi E; Bamba S; Fujiyama Y; Andoh A
J Gastroenterol Hepatol; 2013 Apr; 28(4):613-9. PubMed ID: 23216550
[TBL] [Abstract][Full Text] [Related]
4. Butyrogenic, bifidogenic and slight anti-inflammatory effects of a green kiwifruit powder (Kiwi FFG®) in a human gastrointestinal model simulating mild constipation.
Goya-Jorge E; Bondue P; Gonza I; Laforêt F; Antoine C; Boutaleb S; Douny C; Scippo ML; de Ribaucourt JC; Crahay F; Delcenserie V
Food Res Int; 2023 Nov; 173(Pt 2):113348. PubMed ID: 37803696
[TBL] [Abstract][Full Text] [Related]
5. [Specificity comparison of three Feacalibacterium prausnitzii-specific PCR primer pairs].
Feng J; Hua W; Zhao L; Zhao Y; Shen J
Wei Sheng Wu Xue Bao; 2011 Jun; 51(6):819-27. PubMed ID: 21866708
[TBL] [Abstract][Full Text] [Related]
6. Dietary Factors and Modulation of Bacteria Strains of
Verhoog S; Taneri PE; Roa Díaz ZM; Marques-Vidal P; Troup JP; Bally L; Franco OH; Glisic M; Muka T
Nutrients; 2019 Jul; 11(7):. PubMed ID: 31336737
[No Abstract] [Full Text] [Related]
7. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
[TBL] [Abstract][Full Text] [Related]
8. Growth-promoting effect of alginate on Faecalibacterium prausnitzii through cross-feeding with Bacteroides.
Murakami R; Hashikura N; Yoshida K; Xiao JZ; Odamaki T
Food Res Int; 2021 Jun; 144():110326. PubMed ID: 34053530
[TBL] [Abstract][Full Text] [Related]
9. Faecal microbiota composition in vegetarians: comparison with omnivores in a cohort of young women in southern India.
Kabeerdoss J; Devi RS; Mary RR; Ramakrishna BS
Br J Nutr; 2012 Sep; 108(6):953-7. PubMed ID: 22182464
[TBL] [Abstract][Full Text] [Related]
10. New gene markers for classification and quantification of Faecalibacterium spp. in the human gut.
Tanno H; Chatel JM; Martin R; Mariat D; Sakamoto M; Yamazaki M; Salminen S; Gueimonde M; Endo A
FEMS Microbiol Ecol; 2023 Apr; 99(5):. PubMed ID: 36990641
[TBL] [Abstract][Full Text] [Related]
11. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
[TBL] [Abstract][Full Text] [Related]
12. Faecalibacterium prausnitzii phylotypes in type two diabetic, obese, and lean control subjects.
Hippe B; Remely M; Aumueller E; Pointner A; Magnet U; Haslberger AG
Benef Microbes; 2016 Sep; 7(4):511-7. PubMed ID: 27048834
[TBL] [Abstract][Full Text] [Related]
13. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.
Lopez-Siles M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
ISME J; 2017 Apr; 11(4):841-852. PubMed ID: 28045459
[TBL] [Abstract][Full Text] [Related]
14.
Laursen MF; Laursen RP; Larnkjær A; Mølgaard C; Michaelsen KF; Frøkiær H; Bahl MI; Licht TR
mSphere; 2017; 2(6):. PubMed ID: 29202044
[No Abstract] [Full Text] [Related]
15. Action and function of Faecalibacterium prausnitzii in health and disease.
Ferreira-Halder CV; Faria AVS; Andrade SS
Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):643-648. PubMed ID: 29566907
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterisation of the fermentation profile and prebiotic capacity of gold-fleshed kiwifruit.
Blatchford P; Bentley-Hewitt KL; Stoklosinski H; McGhie T; Gearry R; Gibson G; Ansell J
Benef Microbes; 2015; 6(6):829-39. PubMed ID: 26123782
[TBL] [Abstract][Full Text] [Related]
17. Immunomagnetic Capture of Faecalibacterium prausnitzii Selectively Modifies the Fecal Microbiota and Its Immunomodulatory Profile.
Marcos-Fernández R; Riestra S; Alonso-Arias R; Ruiz L; Sánchez B; Margolles A
Microbiol Spectr; 2023 Feb; 11(1):e0181722. PubMed ID: 36598219
[No Abstract] [Full Text] [Related]
18. Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects.
Benus RF; van der Werf TS; Welling GW; Judd PA; Taylor MA; Harmsen HJ; Whelan K
Br J Nutr; 2010 Sep; 104(5):693-700. PubMed ID: 20346190
[TBL] [Abstract][Full Text] [Related]
19.
Carasi P; Racedo SM; Jacquot C; Elie AM; Serradell ML; Urdaci MC
Front Immunol; 2017; 8():88. PubMed ID: 28239378
[No Abstract] [Full Text] [Related]
20. Kiwifruit-derived supplements increase stool frequency in healthy adults: a randomized, double-blind, placebo-controlled study.
Ansell J; Butts CA; Paturi G; Eady SL; Wallace AJ; Hedderley D; Gearry RB
Nutr Res; 2015 May; 35(5):401-8. PubMed ID: 25931419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
